Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement

Patient Preference and Adherence
Francesco GiorginoAntonella Corcos

Abstract

Adherence to antihyperglycemic medications is often suboptimal in patients with type 2 diabetes, and this can contribute to poor glycemic control, increased hospitalization, and the development of diabetic complications. Reported adherence rates to antihyperglycemics vary widely among studies, and this may be related to differences in methodology for measuring adherence, patient populations, and other factors. Poor adherence may occur regardless of the specific regimen used and whether therapy is oral or injectable, and can be especially common in chronic, asymptomatic conditions, such as type 2 diabetes. More convenient drug-administration regimens and advances in formulations and delivery devices are among strategies shown to improve adherence to antihyperglycemic therapy, especially for injectable therapy. This is exemplified by technological developments made in the drug class of glucagon-like peptide 1-receptor agonists, which are a focus of this narrative review. Dulaglutide, albiglutide, and prolonged-release exenatide have an extended duration of action and can be administered once weekly, whereas such agents as liraglutide require once-daily administration. The convenience of once-weekly versus once-daily administratio...Continue Reading

Citations

Mar 13, 2020·American Journal of Alzheimer's Disease and Other Dementias·Hayato AkimotoDaisuke Kobayashi
Aug 21, 2020·Postgraduate Medicine·Stephen A Brunton, Carol Wysham
Sep 11, 2020·Journal of Clinical Pharmacy and Therapeutics·Jennifer D Goldman
Jul 19, 2019·Clinical Drug Investigation·Katherine A Lyseng-Williamson
May 30, 2020·International Journal of Environmental Research and Public Health·Aida Moreno-JusteAntonio Gimeno-Miguel
Jul 31, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay KalraManilka Sumanatilleke
Sep 9, 2020·Therapeutic Delivery·Iain Simpson
Jun 12, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Roy RasalamAlan Wright
Sep 26, 2020·International Journal of Clinical Practice·Akshay B JainTina Vilsbøll
Oct 18, 2020·Molecular Metabolism·Michael A NauckJuris J Meier
Jul 17, 2021·Frontiers in Endocrinology·Baptist Gallwitz, Francesco Giorgino
Jul 24, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Kristina S BoyeLouis S Matza
Jul 27, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Kevin FernandoDipesh C Patel
Jul 3, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·David R NelsonJieling Chen
Jul 1, 2021·Journal of Veterinary Internal Medicine·Chen GilorTodd Zion
Dec 23, 2021·BMJ Open Diabetes Research & Care·Jordan GemelasNathalie Huguet
Jul 24, 2020·Clinical Diabetes : a Publication of the American Diabetes Association·Iakovos AvramidisGeorgios Pilianidis
Nov 3, 2020·Clinical Diabetes : a Publication of the American Diabetes Association·Jaime P AlmandozCarlos Campos
Feb 26, 2021·Diabetes Spectrum : a Publication of the American Diabetes Association·Diana M IsaacsGeralyn R Spollett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.